Literature DB >> 10909012

Vascular permeability factor/vascular endothelial growth factor in nasal polyps.

S I Vento1, C H Wolff, P J Salven, M L Hytönen, L O Ertama, C H Malmberg.   

Abstract

Although the aetiology of polyps is still, for the most part, unknown, the disease is known to involve tissue oedema. Vascular permeability/vascular endothelial growth factor (VPF/VEGF) is a major inducer of angiogenesis and capillary permeability. This study investigated VPF/VEGF expression in biopsies of nasal polyps from 39 patients and in healthy nasal mucosa from 10 patients by immunohistochemical staining. Staining for VPF/VEGF in the mucosal surface and in the glandular epithelium of nasal polyps was weaker than in normal controls. In two patients, strong staining for VPF/VEGF was found in a granular pattern in mast cells, while the mast cells in other polyposis patients appeared to be largely degranulated. VPF/VEGF was not seen in the mast cells of control patients. Although expression of VPF/VEGF was not increased in the epithelium of the nasal polyps, VPF/VEGF secreted from mast cells may take part in nasal polyp formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909012     DOI: 10.1080/000164800454314

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  6 in total

1.  Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps.

Authors:  Paloma Escobar; Francisco J Márquez; Carolina Carrasco; Sergio Alonso-Orgaz; José Fortes; Carlos Cenjor; Antonio López-Farré
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-11-18       Impact factor: 2.503

2.  Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis.

Authors:  Per Cayé-Thomasen; Knud Larsen; Peter Tingsgaard; Mirko Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

3.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

4.  The Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps.

Authors:  Ming Xu; Daishi Chen; Haojie Zhou; Weiwei Zhang; Jun Xu; Lei Chen
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

5.  Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis.

Authors:  Mihaela Mitroi; Dana Albulescu; Alina Capitanescu; Anca Oana Docea; Gabriela Musat; George Mitroi; Ovidiu Zlatian; Aristidis Tsatsakis; George Tzanakakis; Demetrios A Spandidos; Daniela Calina
Journal:  Mol Med Rep       Date:  2019-02-05       Impact factor: 2.952

Review 6.  Immune cells and angiogenesis.

Authors:  Domenico Ribatti; Enrico Crivellato
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.